Skip to main content
. 2014 Jun;4(2):289–299. doi: 10.1086/675992

Figure 4.

Figure 4

Interleukin (IL)-4 and IL-13 protein levels are increased in the lungs of Schistosoma (Schisto)-exposed mice and partially attenuated by concurrent SU5416 (SU) administration. A, Quantification of IL-4 protein levels, as measured by enzyme-linked immunosorbent assay (ELISA). n = 4 animals/group; ANOVA: P = 0.014; a single asterisk indicates P < 0.05 and a double asterisk P < 0.01 by post hoc Tukey test. B, Immunostain for IL-4 on representative lung sections from mice exposed to carboxymethylcellulose (CMC) or SU, with or without concurrent Schistosoma exposure (arrowheads: positively stained cells; asterisk: vessel lumen; scale bars: 50 μm). C, IL-13 protein levels, as measured by ELISA. n = 4 animals/group; ANOVA P < 0.001; 3 asterisks indicate P < 0.005 by post hoc Tukey test. D, Immunostain for IL-13 on representative lung sections from mice exposed to CMC or SU, with or without concurrent Schistosoma exposure (arrowheads: positively stained cells; asterisk: vessel lumen; scale bars: 100 μm).